Printing your way to personalised healthcare

M3dimaker 1 image

Pharmaceutical 3D Printing for Personalised Medicine

FABRX provides pharmaceutical 3D printers, software, and pharma-ink development services for personalised medicine and small batch manufacture, ideal for drug development and clinicals trials.

M3dimaker 1 image
FABRX provided product and services

Pharmaceutical 3D Printer

The M3DIMAKER is the world's first GMP-ready pharmaceutical 3D printer series with in-built quality control features and exchangeable printheads for fully personalised human and veterinary precision medicine manufacture.

Our printers can be used under extemporaneous/compounding preparation regulation using standard pharmaceutical excipients. Available to purchase or rent.

Software

Personalised prescriptions with just a few button clicks; our comprehensive, easy-to-use M3DIMAKER Studio software packages can be used to control the printer, ensure quality and collect patient feedback, providing simplified workflows and data management.

Printlets™ & Pharma-inks

Our world leading scientists can help you design, develop and test 3D printable pharma-inks for your chosen active ingredients, as well as manufacture small batches of novel medication for clinical trials.

Research & Pharma-ink development

FABRX is involved in a number of projects for personalised medicine with hospitals, universities and pharmaceutical companies. In the next few years, we will have hundreds of pharma-ink protocols that can be implemented into compounding workflows for a range of drugs and treatment pathways, to be prepared by the pharmacist or supplied as pre-filled cartridges for simplified workflows. Below is a pipeline reflecting some of our current projects in a variety of disease and therapeutics areas.

Early Stage
Formulation Development

Preclinical Stage

Clinical Stage

Oncology

Rare diseases

Metabolic disorders

Transplants

Nutraceuticals

Research

FABRX is involved in a number of projects for personalised medicine with research organisations, universities and pharmaceutical companies to develop novel dosage forms using pharmaceutical 3D printing. Below is a pipeline of our current projects in a variety of disease and therapeutics areas.

Early Stage
Formulation Development

Preclinical Stage

Clinical Stage

Oncology

Rare diseases

Metabolic disorders

Transplants

Nutraceuticals

We have collaborators and printers around the world

Map locations
UCL logo
gustave roussy logo
3D limitless logo
Innovate UK logo
EPSRC logo
Basesoft logo
ULisboa logo
CDC logo
Losan Pharma logo
University of Cambridge logo
Vall D'Hebron logo
ULimerick logo
RNIB logo
ULaguna logo
UBrunel log
Heidelberg logo
Hamburg logo
Kaunas Univ logo
UCL logo
gustave roussy logo
3D limitless logo
Innovate UK logo
EPSRC logo
Basesoft logo
ULisboa logo
CDC logo
Losan Pharma logo
University of Cambridge logo
Vall D'Hebron logo
ULimerick logo
RNIB logo
ULaguna logo
UBrunel log
Heidelberg logo
Hamburg logo
Kaunas Univ logo
UMonash logo
Evonik logo
UBradford logo
UFRGS logo
Astra Zeneca logo
Manguinhos logo
Nisso logo
Gatefosse logo
Pfizer logo
UDC logo
IntractPharma logo
Fiocruz logo
Sergas logo
UPorto logo
USC logo
Maryland univ logo
Erasmus mc logo
Alicante hospital Univ logo
UMonash logo
Evonik logo
UBradford logo
UFRGS logo
Astra Zeneca logo
Manguinhos logo
Nisso logo
Gatefosse logo
Pfizer logo
UDC logo
IntractPharma logo
Fiocruz logo
Sergas logo
UPorto logo
USC logo
Maryland univ logo
Erasmus mc logo
Alicante hospital Univ logo

Schedule your consultation today

Get in touch
Quick links
Legal